Company: HURA
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0000950170-25-072745
Chunk: 0

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-05-15
Form: 10-Q
Item: Item 1
Chunk 0
---
TuHURA Biosciences, Inc. 

Condensed Consolidated Balance Sheets

(Unaudited)

     March 31,

     December 31,

     2025

     2024

     Assets

     Current Assets:

     Cash and cash equivalents
      
     $
     6,219,831

     $
     12,657,178

     Deposits, planned business acquisition (note 1)

     6,244,503

     5,994,503

     Advances to acquisition target (note 1)

     858,375

     -

     Other current assets

     1,002,671

     958,708

     Total Current Assets

     14,325,380

     19,610,389

     Property and equipment, net

     151,980

     123,366

     Operating right-of-use assets

     161,317

     199,160

     Other noncurrent assets

     -

     33,769

     Total Assets
      
     $
     14,638,677

     $
     19,966,684

     Liabilities and Stockholders' Equity

     Current Liabilities:

     Accounts payable and accrued expenses
      
     $
     4,617,620

     $
     5,170,166

     Lease liabilities, current

     164,594

     159,844

     Total Current Liabilities

     4,782,214

     5,330,010

     Long-term Liabilities:

     Lease liability, long term

     -

     42,698

     Total Liabilities

     4,782,214

     5,372,708

     Stockholders' Equity:

     Preferred Stock Series A (assumed in merger); $1.00 par value, 278,530 shares   outstanding as of March 31, 2025 and December 31, 2024

     278,530

     278,530

     Common stock, $0.001 par value, 75,000,000 shares authorized; 43,680,396   and 42,323,759 shares issued and outstanding as of March 31, 2025 and   December 31, 2024.

     43,680

     42,324

     Additional paid in capital